Innoviva, Inc.
INVA
$21.19
$0.442.12%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 73.77% | 38.94% | 103.91% | 47.61% | 0.68% |
| Total Other Revenue | -11.81% | -4.57% | -12.19% | 4.98% | 0.22% |
| Total Revenue | 19.25% | 10.56% | 24.84% | 20.44% | 0.39% |
| Cost of Revenue | 110.49% | 68.16% | 298.80% | 205.04% | 20.28% |
| Gross Profit | 8.93% | 4.38% | -5.20% | -7.33% | -1.46% |
| SG&A Expenses | 30.89% | 17.99% | 2.27% | 4.39% | -4.79% |
| Depreciation & Amortization | 1.21% | 1.22% | 1.94% | 1.64% | 1.66% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.67% | 24.98% | 59.52% | 56.78% | 13.09% |
| Operating Income | 5.30% | -5.68% | -11.45% | -15.45% | -10.12% |
| Income Before Tax | -248.79% | 707.85% | 689.81% | 1,328.19% | 284.83% |
| Income Tax Expenses | -376.09% | 499.97% | 608.00% | 40.33% | 293.95% |
| Earnings from Continuing Operations | -230.98% | 500.56% | 707.36% | 7,312.04% | 283.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -230.98% | 500.56% | 707.36% | 7,312.04% | 283.62% |
| EBIT | 5.30% | -5.68% | -11.45% | -15.45% | -10.12% |
| EBITDA | 4.88% | -4.76% | -9.75% | -13.27% | -8.86% |
| EPS Basic | -212.15% | 438.69% | 575.92% | 6,610.82% | 282.64% |
| Normalized Basic EPS | -5.17% | -7.13% | -23.65% | -19.24% | -5.86% |
| EPS Diluted | -247.53% | 398.22% | 590.34% | 5,474.74% | 239.30% |
| Normalized Diluted EPS | 27.40% | -18.83% | -9.96% | -33.95% | -29.93% |
| Average Basic Shares Outstanding | 16.79% | 18.26% | 19.43% | 10.37% | 0.54% |
| Average Diluted Shares Outstanding | -13.06% | 35.31% | 1.26% | 34.97% | 35.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |